PDF Publication Title:
Text from PDF Page: 018
Karthikeyan et al. Nanocurcumin: A Promising Candidate for Therapeutic Applications Bansal, A. K., Dantuluri, A. K. R., Bhaskarao, S. G., and Bapurao, P. Y. (2013). Nanocrystalline solid dispersion compositions and process of preparation. WO Patent Number 2013132457 A2. Barclay, L. R. C., Vinqvist, M. R., Mukai, K., Goto, H., Hashimoto, Y., Tokunaga, A., et al. (2000). On the antioxidant mechanism of curcumin: classical methods are needed to determine antioxidant mechanism and activity. Organic Lett. 2, 2841–2843. doi: 10.1021/ol000173t Basnet, P., Hussain, H., Tho, I., and Skalko-Basnet, N. (2012). Liposomal delivery system enhances anti-inflammatory properties of curcumin. J. Pharmaceut. Sci. 101, 598–609. doi: 10.1002/jps.22785 Basniwal, R. K., Buttar, H. S., Jain, V. K., and Jain, N. (2011). Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J. Agric. Food Chem. 59, 2056–2061. 2011. doi: 10.1021/jf104402t Basniwal, R. K., Khosla, R., and Jain, N. (2014). Improving the anticancer activity of curcumin using nanocurcumin dispersion in water. Nutr. Cancer 66, 1015– 1022. doi: 10.1080/01635581.2014.936948 Beevers, C. S., and Huang, S. (2011). Pharmacological and clinical properties of curcumin. Bot.: Targets Ther. 1, 5–18. doi: 10.2147/BTAT.S17244 Bhandari, R., Gupta, P., Dziubla, T., and Hilt, J. Z. (2016). Single step synthesis, characterization and applications of curcumin functionalized iron oxide magnetic nanoparticles. Mater. Sci. Engineering: C 67, 59–64. doi: 10.1016/ j.msec.2016.04.093 Bhatia, A., Flamer, D., Shah, P. S., and Cohen, S. P. (2016). Transforaminal epidural steroid injections for treating lumbosacral radicular pain from herniated intervertebral discs: a systematic review and meta-analysis. Anesthesia Analgesia 122, 857–870. doi: 10.1213/ANE.0000000000001155 Bhatt, H., Rompicharla, S. V., Komanduri, N., Aashma, S., Paradkar, S., Ghosh, B., et al. (2018). Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity against Human Breast Cancer Cell Line. Curr. Drug Delivery 15, 1271–1283. doi: 10.2174/ 1567201815666180503120113 Bhullar, K., Jha, A., Youssef, D., and Rupasinghe, H. (2013). Curcumin and its carbocyclic analogs: structure-activity in relation to antioxidant and selected biological properties. Molecules 18, 5389–5404. doi: 10.3390/molecules18055389 Bhunchu, S., Rojsitthisak, P., and Rojsitthisak, P. (2015). Effects of preparation parameters on the characteristics of chitosan–alginate nanoparticles containing curcumin diethyl disuccinate. J. Drug Delivery Sci. Technol. 28, 64–72. doi: 10.1016/j.jddst.2015.05.010 Bhunchu, S., Muangnoi, C., and Rojsitthisak, P. (2016). Curcumin diethyl disuccinate encapsulated in chitosan/alginate nanoparticles for improvement of its in vitro cytotoxicity against MDA-MB-231 human breast cancer cells. Die Pharmazie-An Int. J. Pharmaceut. Sci. 71, 691–700. doi: 10.1691/ph.2016.6105 Bicer, N., Yildiz, E., Yegani, A. A., and Aksu, F. (2018). Synthesis of curcumin complexes with iron (iii) and manganese (ii), and effects of curcumin–iron (iii) on Alzheimer’s disease. New J. Chem. 42, 8098–8104. doi: 10.1039/C7NJ04223J Bisht, S., Khan, M. A., Bekhit, M., Bai, H., Cornish, T., Mizuma, M., et al. (2011). A polymeric nanoparticle formulation of curcumin (NanoCurcTM) ameliorates CCl 4-induced hepatic injury and fibrosis through reduction of pro- inflammatory cytokines and stellate cell activation. Lab. Invest. 91, 1383. doi: 10.1038/labinvest.2011.86 Biswas, A. K., Islam, M. R., Choudhury, Z. S., Mostafa, A., and Kadir, M. F. (2014). Nanotechnology based approaches in cancer therapeutics. Adv. Natural Sci.: Nanosci. Nanotechnol. 5, 043001. 10.1088/2043-6262/5/4/043001 Braden, A. R., and Vishwanatha, J. K. (2008). Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics. European Patent Number 2146694A1. Brahmkhatri, V. P., Sharma, N., Sunanda, P., D’souza, A., Raghothama, S., and Atreya, H. S. (2018). Curcumin nanoconjugate inhibits aggregation of N- terminal region (Ab-16) of an amyloid beta peptide. New J. Chem. 42, 19881– 19892. doi: 10.1039/C8NJ03541E Buhrmann, C., Popper, B., Kunnumakkara, A. B., Aggarwal, B. B., and Shakibaei, M. (2019). Evidence That Calebin A, a Component of Curcuma Longa Suppresses NF-kB Mediated Proliferation, Invasion and Metastasis of Human Colorectal Cancer Induced by TNF-b (Lymphotoxin). Nutrients 11, 2904. doi: 10.3390/nu11122904 Chang, P.-Y., Peng, S.-F., Lee, C.-Y., Lu, C.-C., Tsai, S.-C., Shieh, T.-M., et al. (2013). Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin- resistant CAR human oral cancer cells. Int. J. Oncol. 43, 1141–1150. doi: 10.3892/ijo.2013.2050 Chang, T., Trench, D., Putnam, J., Stenzel, M. H., and Lord, M. S. (2016). Curcumin-loading-dependent stability of PEGMEMA-based micelles affects endocytosis and exocytosis in colon carcinoma cells. Mol. Pharmaceut. 13, 924–932. doi: 10.1021/acs.molpharmaceut.5b00820 Chang, M., Wu, M., and Li, H. (2018). Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor- bearing mice. Drug Delivery 25, 1984–1995. doi: 10.1080/10717544.2018.1526227 Chaniyilparampu, R. N., Mungala, M., Kapoor, A., Gokaraju, G. R., Gokaraju, R. R., Bhupathiraju, K., et al. (2010). Topical formulation (s) for the treatment of inflammation, skin and mucosal disorders and other diseases, U.S Patent No 8535693 B2. Chattopadhyay, I., Biswas, K., Bandyopadhyay, U., and Banerjee, R. K. (2004). Turmeric and curcumin: Biological actions and medicinal applications. Curr. Sci. 87, 44–53. Chauhan, S., Jaggi, M., and Yallapu, M. M. (2013). Magnetic nanoparticle formulations, methods for making such formulations, and methods for their use, US Patent Number US 20130245357A1. Chauhan, S., Jaggi, M., and Yallapu, M. M. (2015). Magnetic nanoparticle formulations, methods for making such formulations, and methods for their use, European Patent Number EP2649623B. Chaurasia, S., Chaubey, P., Patel, R. R., Kumar, N., and Mishra, B. (2016). Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies. Drug Dev. Ind. Pharm. 42, 694–700. doi: 10.3109/03639045.2015.1064941 Chen, Y., Wu, Q., Zhang, Z., Yuan, L., Liu, X., and Zhou, L. (2012). Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 17, 5972–5987. doi: 10.3390/molecules17055972 Chen, Y., Du, Q., Guo, Q., Huang, J., Liu, L., Shen, X., et al. (2019). AW/O emulsion mediated film dispersion method for curcumin encapsulated pH- sensitive liposomes in the colon tumor treatment. Drug Dev. Ind. Pharm. 45, 282–291. doi: 10.1080/03639045.2018.1539099 Chen, S., Li, Q., Li, H., Yang, L., Yi, J.-Z., Xie, M., et al. (2020). Long-circulating zein-polysulfobetaine conjugate-based nanocarriers for enhancing the stability and pharmacokinetics of curcumin. Mater. Sci. Engineering: C 109, 110636. doi: 10.1016/j.msec.2020.110636 Chen, X., Chen, X., Shi, X., Gao, Z., and Guo, Z. (2020). Curcumin attenuates endothelial cell fibrosis through inhibiting endothelial-interstitial transformation. Clin. Exp. Pharmacol. Physiol. doi: 10.1111/1440-1681.13271 Cheng, S., Li, L., He, S., Liu, J., Sun, Y., He, M., et al. (2010). GRK5 deficiency accelerates b-amyloid accumulation in Tg2576 mice via impaired cholinergic activity. J. Biol. Chem. 285, 41541–41548. doi: 10.1074/jbc.M110.170894 Chompoosor, A., Saha, K., Ghosh, P. S., Macarthy, D. J., Miranda, O. R., Zhu, Z. J., et al. (2010). The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles. Small 6, 2246– 2249. doi: 10.1002/smll.201000463 Chung, S. S., Dutta, P., Chard, N., Wu, Y., Chen, Q.-H., Chen, G., et al. (2019). A novel curcumin analog inhibits canonical and non-canonical functions of telomerase through STAT3 and NF-kB inactivation in colorectal cancer cells. Oncotarget 10, 4516. doi: 10.18632/oncotarget.27000 Da Silva, A. C., De Freitas Santos, P. D., Do Prado Silva, J. T., Leimann, F. V., Bracht, L., and Gonçalves, O. H. (2018). Impact of curcumin nanoformulation on its antimicrobial activity. Trends Food Sci. Technol. 72, 74–82. doi: 10.1016/ j.tifs.2017.12.004 Damalas, C. A. (2011). Potential Uses of Turmeric (‘Curcuma longa’) Products as Alternative Means of Pest Management in Crop Production. Plant Omics 4, 136. Dandawate, P. R., Vyas, A., Ahmad, A., Banerjee, S., Deshpande, J., Swamy, K. V., et al. (2012). Inclusion complex of novel curcumin analogue CDF and b- cyclodextrin (1: 2) and its enhanced in vivo anticancer activity against pancreatic cancer. Pharmaceut. Res. 29, 1775–1786. doi: 10.1007/s11095-012- 0700-1 Dandekar, P. P., Jain, R., Patil, S., Dhumal, R., Tiwari, D., Sharma, S., et al. (2010). Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation. J. Pharmaceut. Sci. 99, 4992–5010. doi: 10.1002/ jps.22191 Frontiers in Pharmacology | www.frontiersin.org 18 May 2020 | Volume 11 | Article 487PDF Image | Nanocurcumin Promising Candidate for Therapeutic Applications
PDF Search Title:
Nanocurcumin Promising Candidate for Therapeutic ApplicationsOriginal File Name Searched:
fphar-11-00487.pdfDIY PDF Search: Google It | Yahoo | Bing
CO2 Organic Rankine Cycle Experimenter Platform The supercritical CO2 phase change system is both a heat pump and organic rankine cycle which can be used for those purposes and as a supercritical extractor for advanced subcritical and supercritical extraction technology. Uses include producing nanoparticles, precious metal CO2 extraction, lithium battery recycling, and other applications... More Info
Heat Pumps CO2 ORC Heat Pump System Platform More Info
CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com (Standard Web Page)